![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Division of Hematology and Oncology, Department of Internal Medicine, The Ohio State University College of Medicine and Public Health, Columbus, OH 43210
3To whom correspondence should be addressed. E-mail: clinton-1{at}medctr.osu.edu.
We examined the ability of polyphenols from tomatoes and soy (genistein, quercetin, kaempferol, biochanin A, daidzein and rutin) to modulate insulin-like growth factor-I (IGF-I)–induced in vitro proliferation and apoptotic resistance in the AT6.3 rat prostate cancer cell line. IGF-I at 50 µg/L in serum-free medium produced maximum proliferation and minimized apoptosis. Polyphenols exhibited different abilities to modulate IGF-I–induced proliferation, cell cycle progression (flow cytometry) and apoptosis (Annexin V/propidium iodide and terminal deoxynucleotidyltransferase–mediated deoxyuridine 5'-triphosphate nick end labeling). Genistein, quercetin, kaempferol and biochanin A exhibited dose-dependent inhibition of growth with a 50% inhibitory concentration (IC50) between 25 and 40 µmol/L, whereas rutin and daidzein were less potent with an IC50 of >60 µmol/L. Genistein and kaempferol potently induced G2/M cell cycle arrest. Genistein, quercetin, kaempferol and biochanin A, but not daidzein and rutin, counteracted the antiapoptotic effects of IGF-I. Human prostate epithelial cells grown in growth factor–supplemented medium were also sensitive to growth inhibition by polyphenols. Genistein, biochanin A, quercetin and kaempferol reduced the insulin receptor substrate-1 (IRS-1) content of AT6.3 cells and prevented the down-regulation of IGF-I receptor ß in response to IGF-I binding. IGF-I–stimulated proliferation was dependent on activation of mitogen-activated protein kinase/extracellular signal–regulated kinase (ERK) and phosphatidylinositide 3-kinase pathways. Western blotting demonstrated that ERK1/2 was constitutively phosphorylated in AT6.3 cells with no change in response to IGF-I, whereas IRS-1 and AKT were rapidly and sensitively phosphorylated after IGF-I stimulation. Several polyphenols suppressed phosphorylation of AKT and ERK1/2, and more potently inhibited IRS-1 tyrosyl phosphorylation after IGF-I exposure. In summary, polyphenols from soy and tomato products may counteract the ability of IGF-I to stimulate proliferation and prevent apoptosis via inhibition of multiple intracellular signaling pathways involving tyrosine kinase activity.
KEY WORDS: • IGF-I • tomato • soy • polyphenols • prostate
This article has been cited by other articles:
|
|
 |
|
  T. L. Johnson, M. B. Lai, J. C. K. Lai, and A. Bhushan Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A Evid. Based Complement. Altern. Med., February 29, 2008; (2008) nen011v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Varady, D. J. Roohk, and M. K. Hellerstein Dose effects of modified alternate-day fasting regimens on in vivo cell proliferation and plasma insulin-like growth factor-1 in mice J Appl Physiol, August 1, 2007; 103(2): 547 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fang, Q. Zhou, X.-l. Shi, and B.-h. Jiang Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells Carcinogenesis, March 1, 2007; 28(3): 713 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Canene-Adams, B. L. Lindshield, S. Wang, E. H. Jeffery, S. K. Clinton, and J. W. Erdman Jr. Combinations of Tomato and Broccoli Enhance Antitumor Activity in Dunning R3327-H Prostate Adenocarcinomas Cancer Res., January 15, 2007; 67(2): 836 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Davis, C. A. Swanson, R. G. Ziegler, B. Clevidence, J. T. Dwyer, and J. A. Milner Executive Summary Report J. Nutr., August 1, 2005; 135(8): 2014S - 2029S. [Full Text] [PDF]
|
|
|
|
|
|
S. K. Clinton Tomatoes or Lycopene: a Role in Prostate Carcinogenesis? J. Nutr., August 1, 2005; 135(8): 2057S - 2059S. [Full Text] [PDF]
|
|
|
|
|
|
K. Canene-Adams, J. K. Campbell, S. Zaripheh, E. H. Jeffery, and J. W. Erdman Jr The Tomato As a Functional Food J. Nutr., May 1, 2005; 135(5): 1226 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D M Peehl Primary cell cultures as models of prostate cancer development Endocr. Relat. Cancer, March 1, 2005; 12(1): 19 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Adhami, I. A. Siddiqui, N. Ahmad, S. Gupta, and H. Mukhtar Oral Consumption of Green Tea Polyphenols Inhibits Insulin-Like Growth Factor-I-Induced Signaling in an Autochthonous Mouse Model of Prostate Cancer Cancer Res., December 1, 2004; 64(23): 8715 - 8722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Campbell, K. Canene-Adams, B. L. Lindshield, T. W.-M. Boileau, S. K. Clinton, and J. W. Erdman Jr Tomato Phytochemicals and Prostate Cancer Risk J. Nutr., December 1, 2004; 134(12): 3486S - 3492S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Bemis, J. L. Capodice, M. Desai, R. Buttyan, and A. E. Katz A Concentrated Aglycone Isoflavone Preparation (GCP) That Demonstrates Potent Anti-Prostate Cancer Activity In vitro and In vivo Clin. Cancer Res., August 1, 2004; 10(15): 5282 - 5292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Clinton, T. M.-W. Boileau, and J. W. Erdman Jr. RESPONSE: Re: Prostate Carcinogenesis in N-methyl-N-nitrosourea (NMU)-Testosterone-Treated Rats Fed Tomato Powder, Lycopene, or Energy-Restricted Diets J Natl Cancer Inst, April 7, 2004; 96(7): 554 - 555. [Full Text] [PDF]
|
|
